Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab.

Nordal HH, Brun JG, Halse AK, Jonsson R, Fagerhol MK, Hammer HB.

BMC Musculoskelet Disord. 2014 Oct 4;15:335. doi: 10.1186/1471-2474-15-335.

2.

Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.

Curran SA, Hollan I, Erridge C, Lappin DF, Murray CA, Sturfelt G, Mikkelsen K, Førre OT, Almdahl SM, Fagerhol MK, Goodyear CS, Riggio MP.

PLoS One. 2014 May 29;9(5):e98627. doi: 10.1371/journal.pone.0098627. eCollection 2014.

3.

Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study.

Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D.

Am J Hypertens. 2012 Jun;25(6):644-50. doi: 10.1038/ajh.2012.12. Epub 2012 Mar 1.

4.
5.

Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.

Hammer HB, Odegard S, Fagerhol MK, Landewé R, van der Heijde D, Uhlig T, Mowinckel P, Kvien TK.

Ann Rheum Dis. 2007 Aug;66(8):1093-7. Epub 2007 Jan 18.

6.
7.

Calprotectin inhibits matrix metalloproteinases by sequestration of zinc.

Isaksen B, Fagerhol MK.

Mol Pathol. 2001 Oct;54(5):289-92.

8.

High prevalence of NSAID enteropathy as shown by a simple faecal test.

Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, Bjarnason I.

Gut. 1999 Sep;45(3):362-6.

9.
10.

Functional and clinical aspects of the myelomonocyte protein calprotectin.

Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I.

Mol Pathol. 1997 Jun;50(3):113-23. Review. No abstract available.

11.

Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?

Fagerhol MK.

Clin Mol Pathol. 1996 Apr;49(2):M74-9. No abstract available.

12.

Calprotectin as a marker of inflammation in cystic fibrosis.

Golden BE, Clohessy PA, Russell G, Fagerhol MK.

Arch Dis Child. 1996 Feb;74(2):136-9.

13.

Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein).

Naess-Andresen CF, Egelandsdal B, Fagerhol MK.

Clin Mol Pathol. 1995 Oct;48(5):M278-84.

14.

Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen.

Brandtzaeg P, Jones DB, Flavell DJ, Fagerhol MK.

J Clin Pathol. 1988 Sep;41(9):963-70.

15.

PiPclifton: a new alpha 1-antitrypsin allele in an American Negro family.

Hug G, Chuck G, Fagerhol MK.

J Med Genet. 1981 Feb;18(1):43-5. No abstract available.

16.

Protease inhibitor (Pi) phenotypes in chromosome aberrations.

Aarskog D, Fagerhol MK.

J Med Genet. 1970 Dec;7(4):367-70. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk